Sung-Taik Lee

Title: Innovations of Sung-Taik Lee in Ginsenoside Glycosidase

Introduction

Sung-Taik Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of ginsenoside glycosidase derived from Rhodanobacter ginsenosidimutans KCTC22231T. His work focuses on enhancing the bioavailability of ginsenosides, which are important compounds found in ginseng.

Latest Patents

Sung-Taik Lee holds a patent for "Rhodanobacter ginsenosidimutans KCTC22231T-derived ginsenoside glycosidase, and use thereof." This invention relates to a polypeptide that converts PPD (protopanaxadiol)-type saponins into in vivo absorbable and highly active deglycosylated saponins. The polypeptide selectively hydrolyzes a bond at a specific position of ginsenoside, facilitating the conversion process. The patent also includes an amino acid sequence of the polypeptide, a nucleic acid sequence encoding the protein, and methods for preparing and utilizing the ginsenoside glycosidase.

Career Highlights

Sung-Taik Lee is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His research has contributed to advancements in the field of bioscience, particularly in the application of ginsenosides for health benefits. His innovative approach has garnered attention in the scientific community.

Collaborations

Sung-Taik Lee has collaborated with notable colleagues, including Wan-Taek Im and Dong-Shan An. These collaborations have furthered research efforts in the field of biotechnology and have led to significant advancements in ginsenoside research.

Conclusion

Sung-Taik Lee's work in developing ginsenoside glycosidase represents a significant advancement in biotechnology. His innovative contributions have the potential to enhance the therapeutic applications of ginsenosides, making them more accessible for in vivo use.